Table 1:
Participant characteristics of the whole population and divided by sex.
| Mean ± Standard deviation / Percentage (N) | ||
|---|---|---|
| Men (n=2822) | Women (n=1112) | |
| Age (yrs) | 61.1 ± 5.8 | 60.9 ± 5.9 |
| Waist circumference (cm) | 93.7 ± 10.4 | 82.8 ± 12.4 |
| Body mass index (kg/m2) | 26.4 ± 3.7 | 26.7 ± 5.1 |
| Low employment grade | 3.5% (99) | 26.5% (295) |
| Current smokers | 6.2% (174) | 8.4% (92) |
| Antidepressants | 2.5% (69) | 4.4% (49) |
| Anxiolytics | 0.3% (8) | 0.4% (4) |
| Lipid lowering therapy | 12.0% (337) | 9.1% (101) |
| Antihypertensive therapy | 22.6% (637) | 23.7% (263) |
| Systolic blood pressure (mmHg) | 127.4 ± 15.4 | 125.2 ± 173 |
| Diastolic blood pressure (mmHg) | 74.2 ± 10.2 | 72.5 ± 10.4 |
| Heart rate (bpm) | 66.6 ± 11.6 | 67.8 ± 9.7 |
| Fasting glucosea (mmol/L) | 5.43 ± 0.16 | 5.20 ± 0.15 |
| Total cholesterol (mmol/L) | 5.63 ± 0.99 | 5.92 ± 1.01 |
| HDL-cholesterol (mmol/L) | 1.48 ± 0.39 | 1.82 ± 0.49 |
| Triglycerides (mmol/L) | 1.41 ± 0.90 | 1.21 ± 0.68 |
| LDL-cholesterol (mmol/L) | 3.51 ± 0.91 | 3.54 ± 0.96 |
| NonHDL-cholesterol (mmol/L) | 4.15 ± 1.01 | 4.09 ± 1.06 |
| Dyslipidaemia | 60% (1692) | 58% (647) |
| C-reactive proteina (mg/L) | 1.21 ± 1.06 | 1.43 ± 1.13 |
| Interleukin 6a (pg/ml) | 1.88 ± 0.57 | 1.75 ± 0.56 |
| Depression and/or anxiety | 33% (937) | 47% (524) |
| General health questionnaire scoreb | 2.59 ± 5.13 | 3.34 ± 5.80 |
| Intima-media thickness (mm) | 0.80 ± 0.16 | 0.77 ± 0.14 |
HDL = high density lipoprotein, LDL = low density lipoprotein
a
Estimates shown for fasting glucose, C-reactive protein and interleukin 6 are the geometric mean ± standard deviation of the logged values.
b
Estimates shown are for untransformed GHQ. Log(GHQ+1.0) transformation used in all other analyses.